Browsing publications by Professor Ruth Plummer

Newcastle AuthorsTitleYearFull text
Dr Neil Rajan
Dr Thomas Oliphant
Professor Ruth Plummer
Dr James Langtry
Advanced basal cell carcinomas treated by vismodegib and Mohs micrographic surgery: does neoadjuvant treatment have a role?2016
Professor Ruth Plummer
Professor Steve Wedge
Clinical development of new drug-radiotherapy combinations2016
Dr Rachel Pearson
Dr Peter Thelwall
Jim Snell
Jill McKenna
Dr Piotr Pieniazek
et al.
Evaluation of early response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using dynamic contrast-enhanced MRI and diffusion weighted MRI: MARBLE study2016
Dr Rachel Pearson
Dr Peter Thelwall
Jim Snell
Dr Piotr Pieniazek
Dr Rakesh Heer
et al.
Evaluation of early responses to neoadjuvant chemotherapy in muscle-invasive bladder cancer using a dynamic contrast-enhanced MRI and diffusion-weighted MRI: MARBLE study2016
Barry Dent
Laura Ogle
Dr Rachel O'Donnell
Dr Ujjal Mallick
Professor Nicola Curtin
et al.
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers2016
Laura Ogle
Dr James Orr
Catherine Willoughby
Dr Claire Hutton
Dr Stuart McPherson
et al.
Imagestream detection and characterisation of circulating tumour cells - a liquid biopsy for Hepatocellular Carcinoma?2016
Dr Yvette Drew
Dr Martin Highley
Julieann Sludden
Dr James Murray
Dr David Jamieson
et al.
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly (ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer2016
Professor Ruth Plummer
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma2016
Ashleigh McConnell
Dr Robert Ellis
Professor Ruth Plummer
Professor Penny Lovat
Dr Graeme O'Boyle
et al.
The prognostic significance and impact of the CXCR4/CXCR7/CXCL12 axis in primary cutaneous melanoma2016
Dr Yvette Drew
Dr Alastair Greystoke
Professor Ruth Plummer
A first-in-human dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of oral 2-hydroxyoleic acid (2-OHOA) in adult patients (pt) with advanced solid tumors including grade III/IV glioblastoma multiforme (GBM).2015
1234567891011121314